Consequently, the estimated 2 million osteoporosis-related fractures in 2005 could exceed 3 million by 2025, with an associated increase in cost from $16.9 click here billion to $25.3 billion annually [4]. To significantly reduce future fractures, interventions must be broadly applied because most of the population is at some degree of risk. However, public health approaches, Temsirolimus though

essential [5], are of uncertain benefit [6] or cost-effectiveness [7] and may have unexpected adverse outcomes [8]. Pharmacologic prophylaxis is efficacious [9] but has significant side effects [10–12], and in addition, treating the entire community is unaffordable. The key is to discriminate the patients at sufficiently high fracture risk from those at lower risk in whom expensive osteoporosis interventions will have limited value. In the past, risk stratification has relied primarily on bone densitometry, which is both insensitive and nonspecific for fracture outcomes [13–16]; however, sensitivity and specificity can be improved simultaneously by increasing the assessment gradient of risk [17].

This is accomplished in the WHO’s new fracture prediction algorithm, FRAX®, by augmenting bone mineral density (BMD) data with documentation Nutlin-3a nmr of clinical risk factors in order to predict a patient’s 10-year fracture probability [18]. FRAX® now provides the basis for the National Osteoporosis Foundation’s (NOF) individualized approach to fracture prevention [19]. It is important for prediction of the fracture probability to be as accurate as possible, and recently, the opportunity has presented itself to improve

the data used to calculate a patient’s fracture risk in the US version of the FRAX® tool (US-FRAX). This report explains the rationale for these revisions and estimates their impact on results obtained with the fracture tool. US-FRAX 10-year hip fracture probability Since fracture incidence varies by age, sex, race, and geographic region [20], the FRAX® algorithm must be STK38 calibrated to each population using local hip fracture and mortality rates. In the case of the USA, the model was calibrated to data on hip fracture incidence from Olmsted County, MN, combined with national death rates. Hip fracture incidence rates—non-Hispanic whites In lieu of better data at the time, both the original version of the US-FRAX posted February 2008 and the revision posted October 2008 (www.​sheffield.​ac.​uk/​FRAX) were calibrated to hip fracture incidence rates documented for the predominantly white population of Olmsted County during 1989–1991 [21]. Comparably age- and sex-adjusted to the 2000 US white population, the 1989–1991 Olmsted County annual incidence rate for those age 50 years and older was 3.86 per 1,000, quite similar to the 3.91 per 1,000 figure later reported for US whites for the year 2001 [4]. Using these rates, the US-FRAX reports 10-year hip fracture probability estimates similar to those reported for several European countries.